Logo

American Heart Association

  38
  0


Final ID:

Gene Therapy at the Bedside: What Clinicians Need to Know

  • Helms, Adam  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Judge, Daniel  ( Medical University South Carolina , Charleston , South Carolina , United States )
  • Parikh, Victoria  ( Stanford University , San Francisco , California , United States )
  • Author Disclosures:
    Adam Helms: DO have relevant financial relationships ; Consultant:Lexeo:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Preload Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) | Daniel Judge: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Rocket:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Lexeo Therapeutics:Active (exists now) ; Consultant:BridgeBio:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Attralus:Active (exists now) ; Consultant:Alnylam:Active (exists now) | Victoria Parikh: DO have relevant financial relationships ; Consultant:Lexeo Therapeutics:Active (exists now) ; Consultant:Borealis:Active (exists now) ; Consultant:Nuevocor:Active (exists now) ; Advisor:Constantiam Biosciences:Active (exists now) ; Consultant:BioMarin:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Precision Therapy is at the Bedside

Monday, 11/10/2025 , 03:15PM - 04:30PM

Main Event

More abstracts on this topic:
More abstracts from these authors:
Presentation

Alexander Kevin, Judge Daniel

Gene therapy - What is it? Does my patient need it?

Musunuru Kiran, Parikh Victoria, Helms Adam

You have to be authorized to contact abstract author. Please, Login
Not Available